G. R. Girard

发表

Potent and selective small-molecule human urotensin-II antagonists with improved pharmacokinetic profiles.

N. Aiyar, D. Behm, S. Douglas, 2008, Bioorganic & medicinal chemistry letters.

Antitumor activity of bis(diphenylphosphino)alkanes, their gold(I) coordination complexes, and related compounds.

S. Crooke, J. Bartus, C. Mirabelli, 1987, Journal of medicinal chemistry.

An alternate synthesis, x-ray crystal structure and p388 activity of 1,2-bis(dibenzophospholyl-1)ethane †

L. Faucette, D. Eggleston, P. Baures, 1990 .

Antitumor Activity of Bis(diphenylphosphino)alkanes, Their Gold(I) Coordination Complexes, and Related Compounds.

S. Crooke, J. Bartus, C. Mirabelli, 1988 .

1-(carboxybenzyl)imidazole-5-acrylic acids: potent and selective angiotensin II receptor antagonists.

R. Keenan, J. Gleason, J. Hempel, 1991, Journal of medicinal chemistry.

Evaluation of some tetraalkylammonium gold(I) and gold(III) aurate salts for oral antiinflammatory and antiarthritic activity

G. R. Girard, D. T. Hill, M. Dimartino, 1989 .

Orally Active and Potent Inhibitors of γ-Aminobutyric Acid Uptake

C. Kaiser, G. Moonsammy, W. Bondinell, 1985 .

Potent nonpeptide angiotensin II receptor antagonists. 2. 1-(Carboxybenzyl)imidazole-5-acrylic acids.

C. E. Peishoff, R. Keenan, D. Gaitanopoulos, 1993, Journal of medicinal chemistry.

Inhibitors of phenylethanolamine N-methyltransferase and epinephrine biosynthesis. 1. Chloro-substituted 1,2,3,4-tetrahydroisoquinolines.

A. Krog, C. Kaiser, W. Bondinell, 1980, Journal of Medicinal Chemistry.

(. mu. -1,1 prime -Bis(diphenylphosphine)ferrocene)bis(chlorogold): Synthesis, iron-57 and gold-197 Moessbauer spectroscopy, x-ray crystal structure, and antitumor activity

P. Stupik, D. Eggleston, W. Reiff, 1989 .

Tetrahydrothiadiazoloisoquinolines: synthesis and inhibition of phenylethanolamine-N-methyltransferase.

I. Uzinskas, W. Bondinell, G. R. Girard, 1989, Journal of Medicinal Chemistry.

Dichloro(pyridine-2-carboxamido-N1,N2)gold(III), a bis-nitrogen aurocycle: syntheses, gold-197 Mossbauer spectroscopy, and X-ray crystal structure

W. Reiff, G. R. Girard, D. T. Hill, 2003 .

Inhibitors of phenylethanolamine N-methyltransferase and epinephrine biosynthesis: a potential source of new drugs.

J. Hieble, C. Kaiser, C. Perchonock, 1983, Drug metabolism reviews.

INHIBITORS OF PHENYLETHANOLAMINE N-METHYLTRANSFERASE AND EPINEPHRINE BIOSYNTHESIS. 1. CHLORO-SUBSTITUTED 1,2,3,4-TETRAHYDROISOQUINOLINES

A. Krog, C. Kaiser, W. Bondinell, 1980 .

(μ‐1,1′‐Bis(diphenylphosphino)ferrocene)bis(chlorogold): Synthesis, Iron‐57 and Gold‐197 Moessbauer Spectroscopy, X‐Ray Crystal Structure, and Antitumor Activity.

P. Stupik, D. Eggleston, W. Reiff, 1989 .

Correlation of the in vitro cytotoxic and in vivo antitumor activities of gold(I) coordination complexes.

S. Crooke, C. Mirabelli, R. Johnson, 1986, Journal of medicinal chemistry.

Tetrahydrothiadiazoloisoquinolines: Synthesis and Inhibition of Phenylethanolamine‐N‐methyltransferase.

I. Uzinskas, W. Bondinell, G. R. Girard, 1989 .

Synthesis and X-ray crystal structure determination of two pseudopolymorphic forms of μ-[1,2-bis(diphenylphosphino)ethane] bis [chlorogold(I)]: a digold(I) DNA binder

D. Eggleston, G. R. Girard, D. T. Hill, 1985 .

Cytotoxicity and antitumor activity of some tetrahedral bis(diphosphino)gold(I) chelates.

P. Sadler, C. Mirabelli, R. Johnson, 1990, Journal of medicinal chemistry.

Tribromo(triethylphosphine)gold(III), [AuBr3{P(C2H5)3}]

D. Eggleston, G. R. Girard, D. T. Hill, 1984 .

and -N-[(1-benzyl-1H-imidazol-5-yl)-alkyl]-amino acids as angiotensin II AT-1 antagonists

C. E. Peishoff, N. Aiyar, E. Ohlstein, 1995 .

A potent long-acting imidazole-5-acrylic acid angiotensin II AT-1 receptor antagonist

N. Aiyar, D. Brooks, E. Ohlstein, 1994 .

A Potent Long‐Acting Imidazole‐5‐acrylic Acid Angiotensin II AT1 Receptor Antagonist

N. Aiyar, D. Brooks, E. Ohlstein, 1994 .

Imidazole-5-acrylic acids: potent nonpeptide angiotensin II receptor antagonists designed using a novel peptide pharmacophore model.

R. Keenan, J. Hempel, D. Gaitanopoulos, 1992, Journal of medicinal chemistry.

Development of potent and selective small-molecule human Urotensin-II antagonists.

N. Aiyar, D. Behm, S. Douglas, 2008, Bioorganic & medicinal chemistry letters.

Orally active and potent inhibitors of gamma-aminobutyric acid uptake.

C. Kaiser, G. Moonsammy, W. Bondinell, 1985, Journal of medicinal chemistry.